Cell transformation by Polyomavirus middle T (MT) oncoprotein involves binding and activation of several cytoplasmic proteins that participate in growth factorsinduced mitogenic signal transduction to the nucleus. We have previously reported that the AP-1 transcriptional complex is a target for MT during cell transformation. To analyse the interactions between MT and cellular proteins that are required for constitutive AP-1 activation, we compared wild type and transformation-defective MT mutant cell lines. High AP-1 activity, assessed by gel mobility shift assays, displayed by MT-overexpressing cells, is dependent on MT binding to phosphatidylinositol-3 kinase (P13K). Treatment with wortmannin (a speci®c P13K inhibitor) leads to decreased AP-1 activity. Supershift and Western blot analysis with speci®c antisera, indicate that JunB and cJun, but not cFos or FosB are present in the AP-1 complex. The results con®rm the AP-1 complex as a downstream MT target and indicate that AP-1 activation may not be sucient for cell transformation, since two transformation-defective MT mutants (250phe and MT322) display high AP-1 activity.
Introduction
The role played by Polyomavirus T (tumor) antigens (large T, middle T and small T) in cell transformation has been widely investigated (Cherington et al., 1986) . While LT seems to be essential for immortalization of primary cell lines in culture, MT alone can induce morphological transformation and alterations in the growth properties of established cell lines (Schlegel and Bejamin, 1978; Raptis et al., 1985; Cherington et al., 1986) . The ST antigen was shown to be non-essential for cell transformation but to induce cell proliferation to higher saturation densities (Cherington et al., 1986) .
The membrane-associated MT phosphoprotein elicits cell transformation by binding to several proteins that have been implicated in normal cell growth control, modulating their activities (Armelin and Oliveira, 1996; Pallas et al., 1988) , namely: pp60 c-src , c-yes and c-fyn kinases (Courtneidge and Smith, 1983; Kornbluth et al., 1986; Horak et al., 1989; Dunant et al., 1996) , phosphatidylinositol 3-kinase (Whitman et al., 1985; Cohen et al., 1990; Serunian et al., 1990; Su et al., 1995) , protein phosphatase 2A (Glenn and Eckhart, 1993; Campbell et al., 1995) , Shc (Campbell et al., 1994; Dilworth et al., 1994) , phospholipase Cg (Su et al., 1995) and 14-3-3 proteins . Generation of a large number of MT mutants (Markland and Smith, 1987; Druker and Roberts, 1991; Carmichael et al., 1984; Morgan et al., 1988; has been useful in identi®cation of the MT domains that are responsible for binding to these cellular proteins as well as to the analysis of their importance in MT-induced cell transformation (Glenn and Eckhart, 1993; Campbell et al., 1994 Campbell et al., , 1995 Urich et al., 1995; Dahl et al., 1996) .
MT overexpressing cell lines have been shown to display increased pp60 c-src kinase activity (Bolen et al., 1994) high phosphatidylinositol turnover and levels of phosphorylated derivatives (Kaplan et al., 1986; Serunian et al., 1990; Ulug et al., 1990) and activated Ras (bound to GTP) (Srinivas et al., 1994) . Although some correlation between activation of these signal pathways and MT cell transformation can be traced, none of them have been shown to be sucient for malignant cell transformation, since transformationdefective MT mutants that display associated tyrosine kinase, phosphatidylinositol 3-kinase and protein phosphatase activities at wild type levels, were described (Druker and Roberts, 1991; Druker et al., 1990) . In addition, MT was able to induce tumor growth in Src-negative mice and cell transformation in Srcnegative immortalized ®broblasts (Thomas et al., 1993) .
The cellular responses displayed by MT-overexpressing lines and growth factor-stimulated normal cell lines share a number of common features (Kaplan et al., 1987) , since: (a) MT-transformed cell lines are able to grow in the absence of PDGF (platelet derived growth factor) (Rameh and Armelin, 1991 Armelin, , 1992 Armelin et al., 1985; Cherington et al., 1986) ; (b) MT expression leads to high constitutive mRNAs levels of some of the immediate early genes induced by PDGF and to high constitutive AP-1 binding activity Armelin, 1991, 1992; SchoÈ ntal et al., 1992) ; (c) MT modulates cJun phosphorylation and transcriptional activity (Srinivas et al., 1994) .
Here we describe the use of mutant and wild type MT cell lines, generated by retroviral infection, to analyse the relationship between MT binding to and activation of several cellular proteins and increased AP-1 activity. The results show that high MT-induced AP-1 activity is dependent upon MT binding to P13K and is due to JunB and cJun but not to cFos or FosB. MT binding to both P13K and Shc is shown to be necessary for complete cell transformation.
Results

Wild type and mutant MT cell lines
WT and mutant MT overexpressing cell lines, generated through retroviral infection of the Balb/c 3T3 (A31 clone) cell lines were described elsewhere (Druker and Roberts, 1991; Cherington et al., 1986; . Co-immunoprecipitation assays were performed to con®rm MT binding to pp60 s-src , P13K, Shc and PLCg. The results, summarized in Table 1 , are in agreement with those previously described (Armelin and Oliveira, 1996; Carmichael et al., 1984; Campbell et al., 1994; Su et al., 1995) . Thus, mutation in MT tyr 250 completely abolishes Shc binding and insertion of a NPTY motif downstream of the mutated residue, restores this binding (Campbell et al., 1994) . Mutations on tyrosines 315 and 322, abolish, respectively, P13K and PLCg binding (Carmichael et al., 1984; Su et al., 1995) . Deletion of residues 338 ± 347 in the dl1015 mutant decreases its ability to bind to PLCg.
AP-1 binding activity in MT cell lines
Comparison between cellular proteins that bind to the activated PDGF receptor and to the MT molecule shows a number of common features between the normal mitogenic PDGF signal transduction and the MT cell transformation signaling. Among the genes reported to be induced by PDGF are proto-oncogenes of the fos and jun families whose products constitute the AP-1 transcriptional complex that regulates the expression of several genes whose products are required for cell proliferation, through binding to a consensus sequence present in the promoters of these genes (Angel and Karin, 1991) .
We have previously reported that MT overexpressing Balb-3T3 cell lines display high constitutive AP-1 binding activity, in contrast to quiescent 3T3 cells (Rameh and Armelin, 1992) . To determine the MT domains that are necessary for this eect, we performed gel mobility shift assays of nuclear extracts, using a 32 P-labeled consensus AP-1 sequence (described in Materials and methods). As shown in Figure 1 , no AP-1 binding activity can be observed in nuclear extracts from PLJ cells maintained in low serum medium (0.5% FCS-DMEM) for 48 h but this activity is present in cultures restimulated with 10% serum for 2 h. These conditions were chosen based on the results described by Kovary and Bravo (1991) since incubation of quiescent ®broblasts (Balb-3T3) with serum for 2 h leads to the expression of all known components of the Fos and Jun families. 
MT2F MTWT Free oligo Figure 1 AP-1 binding activity in MT cell lines. Nuclear extracts from cells maintained in 0.5% FCS ± DME or restimulated by the addition of FCS to 10% ®nal concentration for 2 h, were incubated with 32 P-labeled AP-1 oligonucleotide, as described in Materials and methods. PLJ cells restimulated with 10% serum for 2 h were used as positive controls. The positions of the AP-1-oligonucleotide complex and free oligonucleotide are shown Figure 1 also shows the results of MT cell lines maintained in low serum medium (0.5% FCS-DMEM). Under these conditions, WTMT, 250phe and 250pheNPTY cells display high AP-1 activity when compared to the control (quiescent PLJ). On the other hand, no AP-1 activity was detected in the MT2F double mutant. These results point to no correlation between MT binding to Shc and activation of the Ras signaling pathway with the constitutive AP-1 activity found in MT transformed cell lines. The results also suggest the possible involvement of PLCg and P13K (both defective in the MT2F double mutant) in MTinduced high AP-1 activity.
MT binding to P13K is necessary for constitutive AP-1 activity
As shown in Figure 1 , substitution of both tyr 315 and tyr 322 in MT, completely abolishes the eect of MT overexpression in the AP-1 activity of these cell lines. To test whether both or only one of these tyr residues are necessary for constitutive AP-1 activity, nuclear extracts from single (315 or 322) and double (MT2F) mutants were used in gel mobility shift assays. The results, shown in Figure 2 , indicate that mutation in MT tyr 315, that abolishes binding and activation of P13K, reduces the constitutive AP-1 activity displayed by MT cell lines to basal levels. This indicates that P13K is participating in MT signaling to the nucleus that leads to activation of the AP-1 transcription factor.
Other signal transduction pathways may be involved in AP-1 activation by MT (Srinivas et al., 1994) . Particularly, MAPK activation has been shown to be associated with AP-1 activation in other systems (Marra et al., 1995; Urich et al., 1997) . Urich et al. (1995) have shown that nuclear translocation of MAPKs by MT or serum is dependent on PI3K activity.
Eect of wortmannin in the constitutive AP-1 activity displayed by wild type MT cell line
The use of wortmannin as a potent and speci®c inhibitor of PI3K (Powis et al., 1994) was shown to block both MAPK translocation to the nucleus in MT overexpressing and in serum stimulated cells (Urich et al., 1995) and activation of pp70 s6k in WT and 250phe mutants (Dahl et al., 1996) . To test whether inactivation of PI3K by this speci®c inhibitor would alter the AP-1 activity displayed by wild type MT cell line, we performed gel shift assays using lysates from cultures treated with 100 nM wortmannin for dierent periods of time (data not shown). Three hours after the addition of wortmannin, no AP-1 activity can be observed. We then performed a gel shift assay of wild type MT lysates prepared 3 h after the addition of dierent concentrations of wortmannin. The results, shown in Figure 3 , indicate that even 10 nM wortmannin is sucient to abolish the AP-1 activity displayed by wild type MT cell line.
Figure 2 MT binding to PI3K is essential for constitutive AP-1 activity in MT cell lines. Gel mobility shift assays for MT mutants (MT315 and MT322) containing one of the two mutations (substitution of tyr 315 to phe or tyr 322 to phe). Quiescent (0.5% FCS ± DME for 48 h) and restimulated (10% FCS ± DME for 2 h) PLJ extracts were used as, respectively, negative and positive controls. Figure 3 AP-1 activity inhibition by wortmannin. Nuclear extracts from WTMT cell lines maintained in low (0.5%) serum medium and treated with wortmannin for 3 h at dierent concentrations (shown in the ®gure) were analysed, by gel shift assay, as described in Materials and methods. As dimethyl sulfoxide (DMSO) was used for wortmannin dilution, 0.03% DMSO (maximum concentration used) was added to the control plates
AP-1 components present in MT overexpressing cell lines
The fact that the 250phe cell line displays constitutive AP-1 activity to similar levels when compared with the 250pheNPTY and the wild type MT overexpressing cell lines, led us to compare the components of the AP-1 complex induced by MT in these cell lines. Super-shift of the shifted AP-1 sequence by incubation of the nuclear extracts with speci®c antibodies to dierent Fos and Jun proteins prior to incubation with the labeled oligonucleotide were performed. All polyclonal antibodies (Santa Crus Biotechnology) were produced against peptides from non-conserved regions of the proteins and the same peptides were used as competitors in these assays. As shown in Figure 4a , cFos is present in the AP-1 complex of nuclear extracts from PLJ cells restimulated with 10% FCS for 2 h. However, cFos was not detected as part of the AP-1 complex in any of the cell lines maintained in low serum medium (0.5% FCS-DMEM for 48 h). The same result was obtained for FosB ( Figure 4b) . Therefore, the constitutive AP-1 activity, displayed by MT cell lines, is not due to activation of cFos or FosB; it remains to be determined whether other members of the Fos family, namely: Fra1 and Fra2 are MT targets.
The same analysis was performed for cJun and JunB; the results, shown in Figure 5 , indicate that these two proteins are present in the AP-1 complex of serum-starved MT cell lines. It is important to note that these proteins are only present in the control PLJ cell line when the cultures are serumrestimulated for 2 h.
JunB is constitutively expressed in MT cell lines
In normal quiescent ®broblasts no or little expression of Fos and Jun proteins is detected (Kovary and Bravo, 1991) . The high AP-1 activity displayed by MT cells could be due to constitutive expression of these proteins and/or post-translational modi®cations that could modify their ability to bind DNA. In Western blot analysis of total protein lysates (Figure 6a , b and c) from cultures maintained in low serum medium or restimulated with 10% serum for 2 h, MT cell lines display similar cFos and FosB expression patterns when compared with the control PLJ cell line, i.e., these proteins are not present in lysates from serumstarved cells but their expression is increased upon serum restimulation. On the other hand, constitutive expression of JunB is displayed by the WT, 250pheNPTY and dl1015 cell lines.
Constitutive AP-1 activity in MT cell lines does not correlate with a transformed phenotype in vitro
The cell lines used in this work were tested for their ability to grow in low serum medium. Comparison of the growth curve results (Figure 7) shows that only the WT and the 250pheNPTY mutant cell lines are able to grow in low serum medium. The other mutants, including 250phe and MT322, that display high AP-1 activity, behave as the control PLJ cells. This implies Plabeled AP-1 oligonucleotide was performed as described in Materials and methods. Extracts from quiescent (0.5% serum for 48 h) or restimulated (by the addition of 10% serum for 2 h) PLJ cells were used as, respectively, negative and positive controls. The wild type and mutant MT extracts were prepared from cultures maintained in 0.5% FCS ± DME for 48 h. Corresponding peptides were used for competition. Positions of the supershifts are shown in the ®gure that MT signaling through binding to several proteins such as Shc, PI3K and PLCg, is necessary for serum independence for growth; however, the AP-1 activation by MT does not seem to be sucient. In addition to activation of the AP-1 complex, MT alters the expression of other gene products that participate in the normal growth control; namely, c-myc protooncogene and the interleukin-like genes JE and KC (Rameh and Armelin, 1991 Armelin, , 1992 .
When assayed for the ability to form colonies in agarose, only the WT and the 250pheNPTY mutant cell lines were capable of forming colonies that are in larger number and size when compared to those seen in the control PLJ cell line. The other mutants behaved as the control (PLJ) line with only individual cells or minute colonies being detected after three weeks (Figure 8 ). Our results indicate that MT binding to the cellular proteins discussed above, but not high AP-1 activity, is necessary for complete anchorageindependent growth.
Discussion
Here, we used dierent MT mutant cell lines (Markland and Smith, 1987; Druker and Roberts, 1991; Carmichael et al., 1984; Morgan et al., 1988; Ling et al., 1992) Figure 8 Colony formation in soft agarose. Cells were plated in 0.6% agarose-10% FCS ± DME and rapidly covered with 0.3% agarose-10% FCS ± DME. Medium was changed every 3 days and the colonies were analysed after 3 weeks. Cell lines in (a) PLJ; (b) 250phe; (c) 250pheNPTY; (d) MT315; (e) MT322; (f) MT2F; (g) MTWT. Photographs taken under a Diaphot Nikon phase microscope at 1006 magni®cation mapping of the MT domain that is responsible for constitutive activation of the AP-1 complex. Binding to PI3K is shown to be necessary for complete activation of AP-1 by MT, since the overexpression of MT mutants (MT2F and MT315) that fail to bind to this cellular protein does not lead to constitutive AP-1 activity. Similar results were obtained with the dl23 mutant that lacks the region from residues 305 ± 330 and that also fails to bind PI3K (data not shown). The constitutively high AP-1 activity displayed by the WTMT cell line was abolished by treatment with wortmannin, a speci®c PI3K inhibitor at the concentrations used (up to 100 nM). This result points to an essential role for PI3K in the AP-1 activation by MT. Urich et al. (1995) have shown that MT activates and induces MAPK nuclear translocation, this eect being dependent upon MT binding to Shc and PI3K. In our experiments, MT binding to Shc and PI3K also seems to be essential for complete MAPK activation (data not shown). This is consistent with cooperation between the Ras and the PI3K pathways for full MAPK activation (Rodriguez-Viciana et al., 1994; Hu et al., 1995; Marra et al., 1995) . However, high AP-1 activity is observed in the 250phe mutant (that does not bind Shc) even though the Erk1 activity displayed by this cell line is low. Interestingly, the 250phe mutant is only 50% less eective than WTMT to induce the uPA promoter (Urich et al., 1995) . As discussed by the authors (Urich et al., 1995) low levels of MAPK in the nucleus, undetectable by immunostaining, could be present in the 250phe cell line. Another possibility is that activation of other kinases, like the Jun kinases, in the 250phe mutant may be responsible for AP-1 activation in this cell line. Dierential mechanisms for ERK and JNK activation (Minden et al., 1994) as well as activation of JNK by oncogenes such as Ras and Src have already been described (Hibi et al., 1993) .
Using the 248m MT mutant (that, like the 250phe mutant, does not bind Shc), others (Ling et al., 1992) have reported the ability of this mutant to bind and induce PI3K activity in vitro, but not to maintain PI3K products in intact cells. Accordingly, the 248, mutant displays lower levels of the PI(3,4,5)P 3 and PI(3,4)P 2 products when compared to wild type MT cell lines. Activation of PI3K leads to activation of pp70 s6k (an essential kinase for G1 progression) in PDGF stimulated (Chung et al., 1994) and MT-transformed cell lines (Dahl et al., 1996) . High pp70 S6k activity observed in wild type and 250 MT mutants but not in 315 MT mutants, can be inhibited by wortmannin (Dahl et al., 1996) suggesting dierences in the downstream signals activated by these two MT mutants. The mechanism by which MT induces the pp70 s6k activity remains to be determined. The dierential behavior observed between the 250 and the 315 MT mutants may re¯ect the importance of the Ras pathway for PI3K signaling. Our results show dierences in AP-1 activity between the 250phe and the MT315 mutants implicating an essential role for MT binding to PI3K, but not to Shc, in AP-1 activation. In addition, the constitutively high AP-1 activity induced by MT is abolished by the use of a speci®c PI3K inhibitor (wortmannin). Expression of a constitutively activated PI3K in the MT315 mutant would be useful to analyse its eect on AP-1 activation.
Supershift analysis using antibodies speci®c to some of the Fos and Jun proteins, revealed that cJun and JunB, but not cFos or FosB are present in the AP-1 complex of MT cell lines. It remains to be determined whether other Fos (Fra1, Fra2) and Jun (JunD) proteins are important components of the AP-1 complex. Western blot analysis revealed that the JunB protein accumulates in cells that express WT and mutant MT that are able to bind to Src, Shc, PI3K and PLCg (250pheNPTY and dl1015) even when cells are maintained in low serum medium for 48 h. Neither cFos nor FosB can be observed in the cell lines maintained in low serum medium for 48 h, but the levels of these proteins can be induced by treatment with 10% serum for 2 h. An interesting result was obtained for the 250phe mutant that displays high AP-1 activity, even though the level of JunB, observed by Western blots, is similar to that of the control PLJ cells. However, supershift analysis shows that JunB is present in the activated AP-1 complex displayed by the 250phe cell line. This could be due to the higher sensitivity of gel shift assays in comparison with Western blots from total protein lysates. Thus, the 250phe cell line may express lower levels of JunB than the WT or the 250pheNPTY lines, but it may still be sucient to confer high AP-1 binding activity. Another possible explanation is that, in addition to constitutive expression of Jun proteins, other activation mechanisms take place. It has been demonstrated that phosphorylation of Ser-63 and Ser-73 residues, present in cJun transactivation domain, and dephosphorylation of Ser-243, Ser-249 and Thr-231 residues, present in the DNA binding domain, increase its DNA binding activity (BineÂ truy et al., 1991) . Overexpression of MT in NIH3T3 cell lines resulted in phosphorylation of the transactivation domain and dephosphorylation of cJun DNA-binding domain, together leading to activation of its transcriptional activity determined by reporter assays (Srinivas et al., 1994) .
The elements downstream to PI3K that can lead to AP-1 activation by MT, also remain to be determined. Sutherland et al. (1993) have shown that pp70 s6k phosphorylates glycogen-synthase kinase-3b (GSK-3) in vitro, leading to its activation. GSK-3 negatively regulates Jun family members, through phosphorylation of residues present in their DNA binding domains (de Groot et al., 1992; Nikolakaki et al., 1993) . Thus, it is possible that induction of Jun DNA binding activity (observed to be dependent on MT bindng to PI3K, in this work) and transcriptional activation by MT (Urich et al., 1995) occurs through inactivation of GSK-3.
The mutant cell lines used in this work were shown to be transformation-defective when analysed for serum requirement for growth and ability to form colonies in agarose, indicating that binding to cellular proteins is necessary for cell transformation by MT. Although constitutive AP-1 activity, shown in this work to be dependent on MT binding to PI3K, can be pointed as one important step in MT cell transformation, no strict correlation with in vitro transformation was found, since mutants 250phe and MT322 are completely transformation defective but still display high AP-1 activity. Overexpression of dominantnegative Jun mutants in the WTMT cell line may contribute decisively to elucidate the role of AP-1 activation in MT cell transformation.
Materials and methods
Cell lines and growth curves
All cell lines used in this work were constructed by infection of Balb-3T3 cells (A31 clone) with wild type and mutant middle T cDNAs using retroviral vectors (Cherington et al., 1986) and have been described elsewhere (Druker and Roberts, 1991; Carmichael et al., 1984; Morgan et al., 1988; . A control cell line (PLJ) was generated by infection with a retroviral vector expressing only the G418 resistance marker. Cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% Fetal Calf Serum (FCS), 1.2 g/l sodium bicarbonate, 25 mg/l ampicillin and 100 mg/l streptomycin. For growth curves, 5610 4 cells were plated per 35 mm plate in 10% FCS ± DME. In the following day, plates were washed twice with phosphatebuered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 8.0 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 ) and the medium was changed to 0.5% FCS ± DME. Duplicate plates were collected by trypsinization at the indicated times, ®xed in 3.7% formaldehyde and counted in a CELM CC-530 electronic cell counter (SaÄ o Paulo, Brazil).
Growth in agarose suspension
Melted agarose was maintained at 458C and mixed with DME and FCS. Cells were plated at low cell density (250 cells/cm 2 ) onto the solid 0.6% agarose in 10% FCS ± DME and rapidly overlayed with the soft 0.3% agarose in 10% FCS ± DME. Liquid medium, carefully placed over the soft agarose layer, was replaced, by aspiration every 3 days and colonies were observed, under a phase microscope, after 3 weeks.
Gel shift assays
Cells were collected from con¯uent cultures (150 mm diameter dishes) maintained in 0.5% FCS ± DME for 48 h or restimulated with 10% FCS ± DME for 2 h, by scraping in PBS and centrifugation. Nuclear extracts were obtained by suspending the cell pellet in 1 ml hypotonic buer (10 mM HEPES, pH 7.9; 10 mM KCl; 0.1 mM EGTA; 1.0 mM DTT; 1.0 mM PMSF; 0.3 units/ml aprotinin). Cells were centrifuged (13 000 g, 15 s, 48C) and the pellet resuspended in 0.4 ml hypotonic buer, for 10 min at 08C. Cells were lysed by the addition of Nonidet P40 to 0.1%, vortexed for 30 s and centrifuged (13 000 g for 30 s, 48C). The pellet was incubated in nuclear extraction buer (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1.0 mM EDTA; 1.0 mM EGTA; 1.0 mM DTT; 1.0 mM PMSF; 0.03 units/ ml aprotinin) for 30 min at 08C. When necessary, cultures were treated with dierent concentrations (from 10 ± 100 nM) of wortmannin. Since wortmannin was diluted in dimethylsulfoxide (DMSO), control plates were treated with the same concentrations of DMSO (®nal concentrations were never higher than 0.03%). Protein samples (5 mg) were incubated with 1 pmol of 32 P-labeled AP-1 oligonucleotides in 20 mM HEPES, pH 7.9; 20% glycerol; 100 mM KCl; 0.2 mM EDTA; 1.0 mM PMSF; 0.5 mM DTT at 308C for 15 min. DNA-protein complexes were separated by electrophoresis through a 4% polyacrylamide gel (30 : 1 acrylamide/bis-acrylamide). For supershift analysis, nuclear extracts were incubated with rabbit polyclonal anti-cFos, anti-FosB, anti-cJun or anti-JunB (Santa Cruz Biotechnology, Santa Cruz, California) for 30 min at 08C, before the addition of the radiolabeled oligonucleotide. For competition assays, control peptides (Santa Cruz Biotechnology, Santa Cruz, California) were incubated with the antibodies for 1 h at room temperature before incubation with the nuclear extracts. The oligonucleotides were purchased from National Biosciences Inc. (NBI). The AP-1 sequence used was as follows: 5'-AAG-CTATGACTCATCCGGTC-3' 3'-TTCGATACTGAGTA-GGCCTG-5'
Western blotting
Con¯uent cultures (100 mm dishes) maintained in 0.5% FCS ± DME or restimulated with 10% FCS ± DME were washed twice in PBS and lysed by the addition of 0.5 ml RIPA buer (1% NP40; 1% sodium deoxycholate; 10 mM Tris-HCl pH 8.0; 1 mM PMSF; 0.03 units/ml aprotinin; 2 mg/ml leupeptin) for 15 min at 48C, under agitation. Lysates were cleared by centrifugation (13 000 g, 15 min, 48C) and normalized for total protein using the Bradford assay (Bio-Rad). One-®fth of the dish (*200 mg of total protein) was fractionated in 10% SDS ± PAGE, transferred to nitrocellulose membranes (Schleicher & Schuell, Keene, NH) and blocked in 5% milk TBST (150 mM NaCl; 50 mM Tris-HCl, pH 7.5; 0.1% Tween 20). Membranes were incubated with polyclonal anti-cFos, anti-FosB or antiJunB (Santa Cruz Biotechnology, Santa Cruz, California) for 2 h at room temperature, washed 36 with TBST and incubated with polyclonal anti-rabbit IgG peroxidase conjugate (Sigma, St Louis, MO, USA) for 30 min. After washing 36 in TBST, membranes were developed by chemiluminescence (ECL-Amersham Life Sciences).
